Atticus Wealth Management’s Moleculin Biotech MBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,784
Closed -$4.73K 531
2024
Q4
$4.73K Sell
2,784
-550
-16% -$935 ﹤0.01% 432
2024
Q3
$9.47K Hold
3,334
﹤0.01% 397
2024
Q2
$11.7K Hold
3,334
﹤0.01% 365
2024
Q1
$19.7K Buy
3,334
+1
+0% +$6 0.01% 325
2023
Q4
$42.9K Buy
+3,333
New +$42.9K 0.02% 260